Genmab | GEN - Trade Creditors



Genmab reported 5M in Trade Creditors for its fiscal quarter ending in March of 2025.


Trade Creditors Change Date
Agios Pharmaceuticals USD 17.53M 3.81M Jun/2025
Almirall EUR 199.39M 50.03M Jun/2025
Amarin USD 45.66M 5.3M Mar/2025
Amgen USD 18.03B 15.63B Jun/2025
argenx SE 852.2M 369.5M Jun/2025
AstraZeneca 23.99B 1.44B Jun/2025
Bayer EUR 6.04B 549M Jun/2025
BioMarin Pharmaceutical 684.25M 390.5M Jun/2025
Demant DKK 964M 306M Jun/2025
Exelixis USD 25.82M 17.02M Jul/2025
Fresenius Medical Care EUR 751.74M 17.26M Jun/2025
Galapagos EUR 133.18M 35.76M Jun/2025
Genmab 5M 1.22M Mar/2025
GlaxoSmithKline 14.82B 329M Jun/2025
GN Store Nord DKK 1.33B 147M Jun/2025
GRIFOLS EUR 878.68M 26.38M Jun/2025
Hikma Pharmaceutical USD 358M 183M Dec/2024
Insmed USD 78.35M 16.95M Jun/2025
Lonza CHF 471M 3M Dec/2024
Merck EUR 1.96B 132M Jun/2025
Novartis USD 4.51B 245M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Roche Holding 4.35B 828M Dec/2024
Sanofi 7.08B 14.54B Jun/2025
UCB 750M 1.66B Dec/2024